BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3520511)

  • 1. Role of antidiuretic activity in the inhibition of renin secretion by vasopressin in anesthetized dogs.
    Schwartz J; Ott C; Morales O; Reid IA
    Peptides; 1986; 7(1):91-6. PubMed ID: 3520511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the vasoconstrictor and antidiuretic activities of vasopressin in inhibition of renin secretion in conscious dogs.
    Schwartz J; Reid IA
    Am J Physiol; 1986 Jan; 250(1 Pt 2):F92-6. PubMed ID: 3510566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs.
    Schwartz J; Liard JF; Ott C; Cowley AW
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H1001-8. PubMed ID: 3840655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a nonpressor analogue of vasopressin on plasma renin activity and salt and water excretion in water-loaded, anesthetized dogs.
    Malayan SA; Reid IA
    Life Sci; 1982 Dec; 31(24):2757-63. PubMed ID: 6759835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the receptors which mediate the stimulation of ACTH secretion by vasopressin in conscious dogs.
    Schwartz J; Reid IA
    Neuroendocrinology; 1986; 42(2):93-6. PubMed ID: 3005898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of AVP and DDAVP on plasma renin activity and electrolyte excretion in conscious dogs.
    Johnson MD; Kinter LB; Beeuwkes R
    Am J Physiol; 1979 Jan; 236(1):F66-70. PubMed ID: 434155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of baroreceptor denervation on the inhibition of renin release by vasopressin.
    Gregory LC; Quillen EW; Keil LC; Reid IA
    Endocrinology; 1988 Jul; 123(1):319-27. PubMed ID: 3289894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on vasopressin release and blood pressure during hemorrhage.
    Shimizu K; Nakao A
    Endocrinol Jpn; 1992 Oct; 39(5):517-23. PubMed ID: 1478192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic effects of vasopressin on plasma renin activity in sodium-restricted dogs.
    Merrill DC; Cowley AW
    Am J Physiol; 1986 Mar; 250(3 Pt 2):F460-9. PubMed ID: 3513620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasopressin on atrial natriuretic peptide release and renal function in dogs.
    Inoue M; Kimura T; Ota K; Iitake K; Shoji M; Sato K; Ota M; Yoshinaga K
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E449-55. PubMed ID: 2972212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal responses to chronic vasopressin infusion.
    Brown AJ; Lohmeier TE; Carroll RG; Meydrech EF
    Am J Physiol; 1986 Apr; 250(4 Pt 2):H584-94. PubMed ID: 3515969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
    Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
    Kopia GA; Valocik RE
    J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin and vasopressin responses to graded reductions in atrial pressure in conscious dogs.
    O'Donnell CP; Thompson CJ; Keil LC; Thrasher TN
    Am J Physiol; 1994 Mar; 266(3 Pt 2):R714-21. PubMed ID: 8160864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs.
    Kaczmarczyk G; Vogel S; Krebs M; Bünger H; Scholz A
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1396-402. PubMed ID: 8945979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic and humoral consequences of chronic infusion of vasopressin in conscious rats.
    Tsuchihashi T; Takata Y; Nakao Y; Tominaga M; Takishita S; Kobayashi K; Abe I; Fujishima M
    Clin Exp Pharmacol Physiol; 1993; 20(7-8):489-95. PubMed ID: 8403529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vasopressin in cardiovascular and neurohormonal responses to intracerebroventricular hypertonic NaCl.
    Kawano Y; Ferrario CM
    Jpn Heart J; 1990 Mar; 31(2):237-44. PubMed ID: 1972413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.